Clinical Trial Update: A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity [Phase 3]

View source ↗

Summary

Phase 3 trial update for HRS-7535 tablets in overweight or obese subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• HRS-7535 (HRS-7535)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Overweight, Obesity | Phase 3 | Status: COMPLETED